Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

Roche will roll out its Accu-Chek Smartguide in the Netherlands, Switzerland and Germany. The company hopes to stand out from competitors with features to predict hypoglycemia.

after several litigation-free years, the parties’ conflict was reignited when DexCom sued Abbott in the US in June 2021, again accusing Abbott of patent infringement for its FreeStyle Libre 2 ...

Both of Abbott's over-the-counter CGMS are based on its popular FreeStyle Libre sensor technology, as Dexcom's prescription-free Stelo follows the popular G6 and G7 CGM technology for people who ...

Additionally, promising data from the Phase 1 trial of ABBV-400, a next-generation c-Met ADC, has led to its advancement in late-line colorectal cancer. Abbott ... like the FreeStyle Libre for ...

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Abbott Labs' key product line in its diabetes care segment is the FreeStyle Libre, a portfolio of continuous glucose monitoring (CGM) devices that allow diabetes patients to keep track of their ...

Thursday, Abbott Laboratories ABT said it is recalling some FreeStyle Libre 3 sensors after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose readings.

Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose readings.

The iLet will soon connect to Abbott's FreeStyle Libre ® 3 Plus continuous glucose sensor, where readings every minute will help the iLet calculate insulin doses. Traditional setup and settings are ...

The iLet will soon connect to Abbott's FreeStyle Libre ® 3 Plus continuous glucose sensor, where readings every minute will help the iLet calculate insulin doses. Traditional setup and settings ...